Quarterly ResultMay 4, 2026, 04:05 PM
Inspire Medical Q1 Revenue +1.6% to $204.6M; Revises FY26 Guidance
AI Summary
Inspire Medical Systems reported Q1 2026 financial results with revenue increasing 1.6% to $204.6 million and adjusted diluted EPS of $0.10. The company faced disruption from coding and reimbursement uncertainty and the WISeR program, which impacted growth. Consequently, Inspire Medical Systems revised its full-year 2026 revenue guidance to $825 million to $875 million, representing a 4% to 10% decline compared to 2025, and expects challenges to persist through the year.
Key Highlights
- Q1 2026 revenue increased 1.6% to $204.6 million.
- Q1 2026 diluted EPS was $(0.39); adjusted diluted EPS was $0.10.
- Q1 2026 operating cash flow was $12.8 million.
- Gross margin increased 180 bps to 86.5%.
- Full-year 2026 revenue guidance revised to $825M-$875M, a 4%-10% decline.
- Full-year 2026 adjusted operating margin guidance is 2%-4%.
- Full-year 2026 adjusted diluted EPS guidance is $0.75-$1.25.